Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- AVR
- Price
- 5.63
- Stock movement down
- -0.39 (-5.93%)
- Company name
- Anteris Technologies Global Corp. Common Stock
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 599.50M
- Ent value
- 610.17M
- Price/Sales
- 313.38
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 64.91%
- 1 year return (CAGR)
- -14.97%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-03-13
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
AVR does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 313.38 |
| Price to Book | - |
| EV to Sales | 318.96 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 96.85M |
| EPS (TTM) | -3.99 |
| FCF per share (TTM) | -3.35 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.91M |
| Gross profit (TTM) | 1.34M |
| Operating income (TTM) | 467.00K |
| Net income (TTM) | -94.14M |
| EPS (TTM) | -3.99 |
| EPS (1y forward) | -0.92 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 70.26% |
| Operating margin (TTM) | 24.41% |
| Profit margin (TTM) | -4921.28% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.58M |
| Net receivables | 32.00K |
| Total current assets | 15.68M |
| Goodwill | 0.00 |
| Intangible assets | 65.00K |
| Property, plant and equipment | 0.00 |
| Total assets | 23.00M |
| Accounts payable | 11.09M |
| Short/Current long term debt | 2.28M |
| Total current liabilities | 21.37M |
| Total liabilities | 23.25M |
| Shareholder's equity | -253.00K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -77.80M |
| Capital expenditures (TTM) | 1.80M |
| Free cash flow (TTM) | -79.07M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -409.38% |
| Return on Invested Capital | -28615.20% |
| Cash Return on Invested Capital | -24033.74% |
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 6.59 |
| Daily high | 6.67 |
| Daily low | 6.17 |
| Daily Volume | 674K |
| All-time high | 8.65 |
| 1y analyst estimate | 15.25 |
| Beta | 0.42 |
| EPS (TTM) | -3.99 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AVR | S&P500 | |
| Current price drop from All-time high | -34.95% | -1.82% |
| Highest price drop | -71.46% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -39.05% | -10.84% |
| Avg time to new high | 17 days | 12 days |
| Max time to new high | 269 days | 1805 days |
COMPANY DETAILS
Marketcap
599.50M
Marketcap category
Small-cap
Description
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Employees
174
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner